sanofi-aventisSanofi-aventis enters the Dow Jones Sustainability World Indexes (DJSI World), the leading global index tracking the financial performance of the leading sustainability-driven companies worldwide. The DJSI World covers the top 10% of the biggest 2,500 companies in the Dow Jones World Index in terms of economic, environmental and social criteria.

This listing on the index recognizes the Group's commitment to making sustainable development a powerful ongoing element in its business activities.

Sanofi-aventis thus ranks among the 8 pharmaceutical leaders in terms of sustainability according the DJSI World.

The 2006 sanofi-aventis Sustainable Development report is available on the Group's sustainability website:

About sanofi-aventis
Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organisation, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information,